Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Therapeutics Q2 Operating Income USD -57.254 Million Vs. IBES Estimate USD -57.1 Million




BRIEF-Cullinan Therapeutics Q2 Operating Income USD -57.254 Million Vs. IBES Estimate USD -57.1 Million


Aug 06 (Reuters) - Cullinan Therapeutics Q2 net income USD -53.704 million.

  • Q2 operating expenses USD 57.254 million
  • Q2 cash & investments USD 356 million

Recent news on Cullinan Therapeutics

See all news